Publications (56 results)
Please use discretion when following external links; Assaypro cannot guarantee the validity and security of all citation links provided.Development of a sensitive ELISA to quantify apolipoprotein CIII in nonhuman primate serum
High-dose DHA has more profound effects on LDL-related features than high-dose EPA: the ComparED study
Distinct patterns of apolipoprotein C-I, C-II, and C-III isoforms are associated with markers of Alzheimer's disease
Cyclodextrin?micellar electrokinetic chromatography of apolipoproteins on human very low?density lipoprotein
Human apolipoprotein CIII levels; evaluation of three assay methods. Scandinavian Journal of Clinical and Laboratory Investigation
Effects of acute exercise on monocyte subpopulations in metabolic syndrome patients
Apolipoprotein CIII and N-terminal prohormone b-type natriuretic peptide as independent predictors for cardiovascular disease in type 2 diabetes
High-Dose DHA Has More Profound Effects on LDL-Related Features Than High-Dose EPA: The ComparED Study
Factorial Effects of Evolocumab and Atorvastatin on Lipoprotein Metabolism
ANGPTL3 serum concentration and rare genetic variants in Finnish population
CHARACTERIZATION OF ANGPTL3 DEFICIENCY AND MOLECULAR MECHANISMS OF ANGPTL3 DEFICIENCYINDUCED HYPOLIPIDEMIA
Prevalence and Genetics of Non-Alcoholic Fatty Liver Disease
QUANTITATIVE DETERMINATION OF PROTEIN APOCIII IN SERUM: COMPARISON OFTHREE ASSAY METHODS
Inter-relationships between proprotein convertase subtilisin/kexin type 9, apolipoprotein C-III and plasma apolipoprotein B-48 transport in obese subjects: a stable isotope study in the postprandial state
PCSK9, apolipoprotein E and lipoviral particles in chronic hepatitis C genotype 3: Evidence for genotype-specific regulation of lipoprotein metabolism
Effect of Mediterranean Diet With and Without Weight Loss on Apolipoprotein B100 Metabolism in Men With Metabolic Syndrome
Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling
Biomarkers for monitoring treatment of neuropsychiatric diseases
Impaired lipid transport in gestational diabetes mellitus
Characterization of the fetal blood transcriptome and proteome in maternal anti-fetal rejection: evidence of a distinct and novel type of human fetal systemic inflammatory response
Apo E Derived from Adipose Tissue Does Not Suppress Atherosclerosis or Correct Hyperlipidemia in EKO Mice
Longitudinal Analysis of Maternal Plasma Apolipoproteins in Pregnancy: A Targeted Proteomics Approach
An Apolipoprotein CIII-Derived Peptide, Hatktak, Activates Macromolecular Activators of Phagocytosis from Platelets (MAPPs). Lipoproteins - Role in Health and Diseases
Biomarkers for monitoring treatment of neuropsychiatric diseases
Genetic variation in PNPLA3 but not APOC3 influences liver fat in non-alcoholic fatty liver disease
Development of a Sensitive ELISA to Quantify Apolipoprotein CIII in Non-human Primate Serum
Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a Pilot and Replication Study
The Apolipoprotein C-I Content of Very-Low-Density Lipoproteins Is Associated with Fasting Triglycerides, Postprandial Lipemia, and Carotid Atherosclerosis
Elevated Ratio of Maternal Plasma ApoCIII to ApoCII in Preeclampsia
* Hu Y et al. (2021) Distinct patterns of apolipoprotein C-I, C-II, and C-III isoforms are associated with markers of Alzheimer's disease. J Lipid Res. 62:100014.
* Shieh YT et al. (2020) Cyclodextrin?micellar electrokinetic chromatography of apolipoproteins on human very low?density lipoprotein. Electrophoresis. 41(15):1333-1343.
* Sandin A et al. (2020) Human apolipoprotein CIII levels; evaluation of three assay methods. Scandinavian Journal of Clinical and Laboratory Investigation. Scand J Clin Lab Invest. 80(3):230-235
* Wonner R et al. (2018) Effects of acute exercise on monocyte subpopulations in metabolic syndrome patients. Cytometry B Clin Cytom. 94(4):596-605.
* Colombo M et al. (2018) Apolipoprotein CIII and N-terminal prohormone b-type natriuretic peptide as independent predictors for cardiovascular disease in type 2 diabetes. Atherosclerosis.274:182-190
* Allaire J et al. (2018) High-Dose DHA Has More Profound Effects on LDL-Related Features Than High-Dose EPA: The ComparED Study. J Clin Endocrinol Metab. 103(8):2909-2917.
* Watts GF (2017) Factorial Effects of Evolocumab and Atorvastatin on Lipoprotein Metabolism. Circulation. 135(4):338-351.
* Tikka A et al. (2017) ANGPTL3 serum concentration and rare genetic variants in Finnish population. Scand J Clin Lab Invest. 77(8):601-609.
* Tikka A (2017) CHARACTERIZATION OF ANGPTL3 DEFICIENCY AND MOLECULAR MECHANISMS OF ANGPTL3 DEFICIENCYINDUCED HYPOLIPIDEMIA. University of Helsinki.
* Hyysalo J (2017) Prevalence and Genetics of Non-Alcoholic Fatty Liver Disease. University of Helsinki.
* Sandin A et al. (2015) QUANTITATIVE DETERMINATION OF PROTEIN APOCIII IN SERUM: COMPARISON OFTHREE ASSAY METHODS. Clin. Chem Lab Med 2015:53, Special Suppl, pp S248
* Chan DC et al. (2015) Inter-relationships between proprotein convertase subtilisin/kexin type 9, apolipoprotein C-III and plasma apolipoprotein B-48 transport in obese subjects: a stable isotope study in the postprandial state. Clin Sci (Lond). 128(6):379-85.
* Bridge SH et al.(2015) PCSK9, apolipoprotein E and lipoviral particles in chronic hepatitis C genotype 3: Evidence for genotype-specific regulation of lipoprotein metabolism. J Hepatol. 2015 Apr;62(4):763-70.
* Richard C et al. (2014) Effect of Mediterranean Diet With and Without Weight Loss on Apolipoprotein B100 Metabolism in Men With Metabolic Syndrome. Arterioscler Thromb Vasc Biol. 34:433-438
* Riwanto M et al. (2013) Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling. Circulation. 127(8):891-904
* Pi B and Bilello J (2013) Biomarkers for monitoring treatment of neuropsychiatric diseases. Patent application EP20110846638
* Nichols SKF et al. (2013) Impaired lipid transport in gestational diabetes mellitus. Journal of Diabetes Research & Clinical Metabolism. doi: 10.724/2050-0866-2-22
* Lee JH et al. (2013) Characterization of the fetal blood transcriptome and proteome in maternal anti-fetal rejection: evidence of a distinct and novel type of human fetal systemic inflammatory response. Am J Reprod Immunol. 2013 Oct;70(4):265-84. doi: 10.1111/aji.12142. Epub 2013 Jul 30
* Huang ZH et al. (2013) Apo E Derived from Adipose Tissue Does Not Suppress Atherosclerosis or Correct Hyperlipidemia in EKO Mice. J. Lipid Res. 54(1):202-213.
* Flood-Nichols SK et al. (2013) Longitudinal Analysis of Maternal Plasma Apolipoproteins in Pregnancy: A Targeted Proteomics Approach. Molecular & Cellular Proteomics 12.1
* Sakamoto H et al. (2012) An Apolipoprotein CIII-Derived Peptide, Hatktak, Activates Macromolecular Activators of Phagocytosis from Platelets (MAPPs). Lipoproteins - Role in Health and Diseases. Chapter 31. p.721-740
* Pi B et al. (2012) Biomarkers for monitoring treatment of neuropsychiatric diseases. Patent application number: US20120178118 A1
* Hyysalo J (2012) Genetic variation in PNPLA3 but not APOC3 influences liver fat in non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2012 May;27(5):951-956
* Wang Y et al. (2011) Development of a Sensitive ELISA to Quantify Apolipoprotein CIII in Non-human Primate Serum. J Lipid Res. 52(6):1265-1271
* Papakostas GI (2011) Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a Pilot and Replication Study. Mol Psychiatry 18(3):332-9.
* Hansen JB et al. (2011) The Apolipoprotein C-I Content of Very-Low-Density Lipoproteins Is Associated with Fasting Triglycerides, Postprandial Lipemia, and Carotid Atherosclerosis. J Lipids. 2011:271062.
* Flood-Nichols SK et al. (2011) Elevated Ratio of Maternal Plasma ApoCIII to ApoCII in Preeclampsia. Reprod Sci. 18(5):493-502.